TOSTREL

Serial Number 75866689
606

Registration Progress

Application Filed
Dec 7, 1999
Under Examination
Nov 14, 2000
Approved for Publication
Jul 21, 2000
Published for Opposition
Aug 22, 2000
Registered

Trademark Image

TOSTREL

Basic Information

Serial Number
75866689
Filing Date
December 7, 1999
Published for Opposition
August 22, 2000
Abandonment Date
May 15, 2003
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 15, 2003
Classes
005

Rights Holder

Cellegy Pharmaceuticals, Inc.

03
Address
349 Oyster Point Blvd., Suite 200
South San Francisco, CA 94080

Ownership History

Cellegy Pharmaceuticals, Inc.

Original Applicant
03
South San Francisco, CA

Cellegy Pharmaceuticals, Inc.

Owner at Publication
03
South San Francisco, CA

Legal Representation

Attorney
Priscilla Mark

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

16 events
Date Code Type Description Documents
Dec 31, 2003 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 31, 2003 EX4G S SOU EXTENSION 4 GRANTED Loading...
Nov 8, 2002 MAIL I PAPER RECEIVED Loading...
Nov 5, 2002 EXT4 S SOU EXTENSION 4 FILED Loading...
May 30, 2002 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 13, 2002 MAIL I PAPER RECEIVED Loading...
May 13, 2002 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 24, 2001 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 24, 2001 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 18, 2001 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 7, 2001 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 14, 2000 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 22, 2000 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 21, 2000 NPUB O NOTICE OF PUBLICATION Loading...
May 4, 2000 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 3, 2000 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
Transdermal gel for hormone therapy; testosterone gel; and hormone preparations for use in the treatment of hypogonadism
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005